ECSP992975A - NEFAZODONE DOSAGE FORM - Google Patents
NEFAZODONE DOSAGE FORMInfo
- Publication number
- ECSP992975A ECSP992975A ECSP992975A ECSP992975A EC SP992975 A ECSP992975 A EC SP992975A EC SP992975 A ECSP992975 A EC SP992975A EC SP992975 A ECSP992975 A EC SP992975A
- Authority
- EC
- Ecuador
- Prior art keywords
- nefazodone
- release
- compositions
- dosage form
- demonstrate
- Prior art date
Links
- 229960001800 nefazodone Drugs 0.000 title abstract 4
- VRBKIVRKKCLPHA-UHFFFAOYSA-N nefazodone Chemical compound O=C1N(CCOC=2C=CC=CC=2)C(CC)=NN1CCCN(CC1)CCN1C1=CC=CC(Cl)=C1 VRBKIVRKKCLPHA-UHFFFAOYSA-N 0.000 title abstract 4
- 239000002552 dosage form Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000013265 extended release Methods 0.000 abstract 1
- 239000012729 immediate-release (IR) formulation Substances 0.000 abstract 1
- 229960002441 nefazodone hydrochloride Drugs 0.000 abstract 1
- DYCKFEBIOUQECE-UHFFFAOYSA-N nefazodone hydrochloride Chemical compound [H+].[Cl-].O=C1N(CCOC=2C=CC=CC=2)C(CC)=NN1CCCN(CC1)CCN1C1=CC=CC(Cl)=C1 DYCKFEBIOUQECE-UHFFFAOYSA-N 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Las composiciones de nefazodona de liberación prolongada, que contienen clorhidrato de nefazodona, polímeros de gelificación iónico y no iónico, un agente hidrofilico insoluble, y excipíentes opcionales farmacéuticamente aceptables, demuestran liberación de la nefazodona, modulada por el pH. Estas composiciones son formuladas en formas de dosis unitaria para la administración oral mejorada. Los mejoramientos comprenden un perfil prolongado de liberación del fármaco, proporcionando niveles comparativos de nefazodona con respecto a las formas de dosificación de liberación inmediata y, además, que demuestran la falta de un efecto por alimento.Nefazodone extended-release compositions, containing nefazodone hydrochloride, ionic and nonionic gelling polymers, an insoluble hydrophilic agent, and pharmaceutically acceptable optional excipients, demonstrate pH-modulated release of nefazodone. These compositions are formulated in unit dose forms for improved oral administration. The enhancements comprise a prolonged drug release profile, providing comparative levels of nefazodone with respect to immediate release dosage forms, and further demonstrating the lack of an effect per food.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP992975 ECSP992975A (en) | 1999-06-02 | 1999-06-02 | NEFAZODONE DOSAGE FORM |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP992975 ECSP992975A (en) | 1999-06-02 | 1999-06-02 | NEFAZODONE DOSAGE FORM |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP992975A true ECSP992975A (en) | 1999-08-12 |
Family
ID=42043964
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP992975 ECSP992975A (en) | 1999-06-02 | 1999-06-02 | NEFAZODONE DOSAGE FORM |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP992975A (en) |
-
1999
- 1999-06-02 EC ECSP992975 patent/ECSP992975A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY25544A1 (en) | NEFAZODONE DOSAGE FORM | |
| UY27908A1 (en) | FORMULATIONS AND DOSAGE FORMS FOR THE CONTROLLED ADMINISTRATION OF TOPIRAMATO | |
| ES2167061T3 (en) | DOSAGE FORMS TO IMPROVE ERECTILE DYSFUNCTION IN MALE SEX PATIENTS. | |
| AR039744A1 (en) | METHODS AND DOSAGE FORMS TO INCREASE THE SOLUBILITY OF PHARMACOS COMPOSITIONS FOR CONTROLLED ADMINISTRATION | |
| CR6326A (en) | PHARMACEUTICAL FORMULATIONS OF CONTROLLED LIBERATION | |
| CO5190672A1 (en) | COMPOSITION FOR ORAL DOSAGE, INSTANT DISSOLUTION | |
| CO5170471A1 (en) | MODIFIED RELEASE TABLETS INCLUDING AMOXYLIN AND POTASSIUM CLAVULANATE | |
| EE05022B1 (en) | Use of Pregelatinised Starch in a Hydrophilic Controlled Release Preparation and a Hydrophilic Controlled Release Preparation | |
| CR9842A (en) | CELECOXIB COMPOSITIONS | |
| ES2117015T3 (en) | COMPOSITIONS CONTAINING SUMATRIPTAN. | |
| ECSP083351A (en) | PHARMACEUTICAL COMPOSITIONS | |
| DE60121301D1 (en) | Flibanserin for the treatment of extrapyramidal movement disorders | |
| AR034517A1 (en) | PHARMACEUTICAL FORMULATION | |
| PT1383752E (en) | 3-PIPERIDINOPROPYOPHENONES DETERMINED AS WELL AS PHARMACONS CONTAINING THESE COMPOUNDS | |
| CO5200840A1 (en) | COMBINATION OF ACTIVE SUBSTANCES WITH CLONIDINE | |
| DK1608349T3 (en) | Oral delivery system comprising an antibacterial and an anti-inflammatory agent | |
| CO5580741A2 (en) | PHARMACEUTICAL COMPOSITION INCLUDING A 5HT1 RECEIVER AGONIST | |
| ES2130081B1 (en) | TRIMEBUTINE MALEATE TABLET WITH LAMINAR COATING. | |
| ATE262893T1 (en) | DOSAGE FORMS FOR THE TREATMENT OF ORAL MYCOSES | |
| PE20030830A1 (en) | AMBROXOL FOR THE TREATMENT OF PAINFUL STATES IN THE ORAL CAVITY AND PHARYNGEAL | |
| ES2194618T1 (en) | ORALALLY DISINTEGRABLE COMPOSITION THAT MIRTAZAPINE INCLUDES. | |
| AR034142A1 (en) | A PHARMACEUTICAL COMPOSITION, METHOD FOR MANUFACTURING A MEDICINAL BASED ON SUCH COMPOSITION AND USE OF THE COMPOSITION | |
| AR027394A1 (en) | USE OF MIRTAZAPINE FOR THE TREATMENT OF SOIL DISORDERS | |
| AR048318A1 (en) | ORAL MATRIX FORMULATIONS THAT INCLUDE LICARBAZEPINA | |
| AR043370A1 (en) | PHARMACEUTICAL COMPOSITIONS OF ORAL ADMINISTRATION AND METHODS TO AVOID FOOD-DRUG INTERACTION |